MEEDER ASSET MANAGEMENT INC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 809443 DUBLIN, OH

Position in CPRX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$257,305

+$193,139 QoQ

Shares Held

10,392

+251.4% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MEEDER ASSET MANAGEMENT INC holds $7,091,404 across 37 Biotechnology names. CPRX ranks #3 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	6,094	$4,708,465
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,424	$1,528,950
3	CPRX	Catalyst Pharmaceuticals, Inc. This page	10,392	$257,305
4	BMRN	Biomarin Pharmaceutical Inc	1,838	$103,828
5	ADMA	Adma Biologics, Inc.	9,759	$87,928
6	VCEL	Vericel Corp	1,900	$61,123
7	MNPR	Monopar Therapeutics	637	$34,901
8	ENTA	Enanta Pharmaceuticals Inc	2,025	$25,575

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$257,305	10,392	+251.4%	Shares	Sole	2026-05-07
2025-06-30	$64,166	2,957	-68.7%	Shares	Sole	2025-08-07
2025-03-31	$228,944	9,441	-20.2%	Shares	Sole	2025-05-07
2024-12-31	$246,954	11,833	+163.1%	Shares	Sole	2025-02-12
2024-09-30	$89,400	4,497	0.0%	Shares	Sole	2024-11-07
2024-06-30	$69,658	4,497	+20340.9%	Shares	Sole	2024-08-08
2022-12-31	$409	22	-77.3%	Shares	Sole	2023-02-14
2022-09-30	$1,244	97	-99.5%	Shares	Defined	2022-11-14
2021-09-30	$98,477	18,581	0.0%	Shares	Defined	2021-11-08
2021-06-30	$106,840	18,581	0.0%	Shares	Defined	2021-08-09
2021-03-31	$85,654	18,581	-0.0%	Shares	Defined	2021-04-28
2020-09-30	$55,184	18,582	0.0%	Shares	Defined	2020-11-02
2020-06-30	$85,846	18,582	+35.2%	Shares	Defined	2020-08-11
2020-03-31	$52,923	13,747	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.